First report of a nonmetallocarbapenemase class A carbapenemase in an Enterobacter cloacae isolate from Colombia

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 7, 2013, Pages 3457-

  Blanco, V M ^a   Rojas, L J ^a   De La Cadena, E ^a   Maya, J J ^a   Camargo, R D ^b   Correa, A ^a   Quinn, J P ^c   Villegas, M V ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b Instituto de Enfermedades Hepáticas y Digestivas   (Colombia)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEMASE; CEFEPIME; CEFOXITIN; CEPHALOSPORIN; CIPROFLOXACIN; DORIPENEM; ERTAPENEM; IMIPENEM; MEROPENEM; NONMETALLOCARBAPENEMASE CLASS A; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TIGECYCLINE; UNCLASSIFIED DRUG;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL PERITONITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; CLINICAL FEATURE; COLOMBIA; ENTEROBACTER CLOACAE; FEMALE; HUMAN; LETTER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGMOID CARCINOMA;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; COLOMBIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84879023652     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02425-12     Document Type: Letter

References (9)

1. Nordmann P, Mariotte S, Naas T, Labia R, Nicolas MH. 1993. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 37:939-946. (Pubitemid 23141300)
2. Pottumarthy S, Moland ES, Juretschko S, Swanzy SR, Thomson KS, Fritsche TR. 2003. NmcA carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America. Emerg. Infect. Dis. 9:999-1002. (Pubitemid 36944523)
3. Radice M, Power P, Gutkind G, Fernández K, Vay C, Famiglietti A, Ricover N, Ayala JA. 2004. First class A carbapenemase isolated from Enterobacteriaceae in Argentina. Antimicrob. Agents Chemother. 48:1068-1069. (Pubitemid 38280374)
4. Deshpande LM, Jones RN, Fritsche TR, Sader HS. 2006. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb. Drug Resist. 12:223-230. (Pubitemid 46110652)
5. Osterblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J. 2012. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11). J. Antimicrob. Chemother. 67:2860-2864.
6. CLSI. 2012. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Coudron PE, Moland ES, Thomson KS. 2000. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J. Clin. Microbiol. 38:1791-1796. (Pubitemid 30253917)
8. Naas T, Nordmann P. 1994. Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc. Natl. Acad. Sci. U. S. A. 91:7693-7697. (Pubitemid 24238251)
9. Naas T, Massuard S, Garnier F, Nordmann P. 2001. AmpD is required for regulation of expression of NmcA, a carbapenem-hydrolyzing betalactamase of Enterobacter cloacae. Antimicrob. Agents Chemother. 45: 2908-2915. (Pubitemid 32906691)